Literature DB >> 29108480

Short-Term Homing of Hyaluronan-Primed Cells: Therapeutic Implications for Osteoarthritis Treatment.

Giovanna Desando1, Isabella Bartolotti1, Carola Cavallo1, Antonella Schiavinato2, Cynthia Secchieri2, Elizaveta Kon3, Giuseppe Filardo4, Maurizio Paro5, Brunella Grigolo6.   

Abstract

The evaluation of key factors modulating cell homing following injection can provide new insights in the comprehension of unsolved biological questions about the use of cell therapies for osteoarthritis (OA). The main purpose of this in vivo study was to investigate the biodistribution of an intra-articular injection of mesenchymal stromal cells (MSCs) and bone marrow concentrate (BMC) in a rabbit OA model and whether the additional use of sodium hyaluronate (HA) could modulate their migration and delay joint degeneration. OA was surgically induced in adult male New Zealand rabbits. A group of animals was used to test the biodistribution of labeled cells alone or with HA at 7 and 14 days to investigate cell migration. The efficacy of treatments was evaluated in other experimental groups at 2 months. Histology and immunohistochemistry for markers identifying anabolic and catabolic processes in the cartilage and meniscus, or macrophage subset population in the synovial membrane, were performed. Kruskal-Wallis test, followed by post hoc Dunn's test, and Spearman's rank-order correlation method were used. MSCs and BMC preferentially migrate toward tissue areas showing OA features in the meniscus and cartilage and in detail near inflammatory zones in the synovial membrane. The combination with HA contributed to boost cell migration toward articular cartilage. In general, both labeled cells combined with HA were found near cell cluster and fissures in the cartilage and meniscus, respectively, and close to areas of synovial membrane showing mainly anti-inflammatory macrophages. A promotion of joint repair was observed at different levels for all treatments, although BMC-HA treatment resulted as the best strategy to support joint repair. This last, displayed a good protein expression of type II collagen in the cartilage, as well as the presence of anti-inflammatory macrophages in the synovial membrane at 2 months from the treatment. Studies tracking cell biodistribution indicate that priming progenitor cells with HA modulated cell homing favoring not only attachment but also their integration within articular cartilage.

Entities:  

Keywords:  cell migration; cell-based therapies; macrophage subset population; osteoarthritis; sodium hyaluronate

Mesh:

Substances:

Year:  2017        PMID: 29108480     DOI: 10.1089/ten.TEC.2017.0336

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  11 in total

Review 1.  Does vehicle-based delivery of mesenchymal stromal cells give superior results in knee osteoarthritis? Meta-analysis of randomized controlled trials.

Authors:  Madhan Jeyaraman; B Shivaraj; Shiva Kumar Bingi; Rajni Ranjan; Sathish Muthu; Manish Khanna
Journal:  J Clin Orthop Trauma       Date:  2022-01-19

2.  Mesenchymal Stem Cell Therapy for Osteoarthritis: Practice and Possible Promises.

Authors:  Nahid Nasiri; Reihaneh Nateghi; Fatemeh Zarei; Samaneh Hosseini; Mohamdreza Baghaban Eslaminejad
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine.

Authors:  Isabella Bartolotti; Livia Roseti; Mauro Petretta; Brunella Grigolo; Giovanna Desando
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

4.  Intra-articular Injection of Cell-laden 3D Microcryogels Empower Low-dose Cell Therapy for Osteoarthritis in a Rat Model.

Authors:  Dan Xing; Wei Liu; Bin Wang; Jiao Jiao Li; Yu Zhao; Hui Li; Aifeng Liu; Yanan Du; Jianhao Lin
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 5.  Bone marrow concentrate injections for the treatment of osteoarthritis: evidence from preclinical findings to the clinical application.

Authors:  Carola Cavallo; Angelo Boffa; Luca Andriolo; Simone Silva; Brunella Grigolo; Stefano Zaffagnini; Giuseppe Filardo
Journal:  Int Orthop       Date:  2020-07-13       Impact factor: 3.075

Review 6.  Narrative review of the choices of stem cell sources and hydrogels for cartilage tissue engineering.

Authors:  Zhantao Deng; Jiewen Jin; Shuai Wang; Fangjie Qi; Xuepan Chen; Chang Liu; Yanbing Li; Yuanchen Ma; Fengjuan Lyu; Qiujian Zheng
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  Role of Scaffolds, Subchondral, Intra-Articular Injections of Fresh Autologous Bone Marrow Concentrate Regenerative Cells in Treating Human Knee Cartilage Lesions: Different Approaches and Different Results.

Authors:  Jacques Hernigou; Pascale Vertongen; Joanne Rasschaert; Philippe Hernigou
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

8.  Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.

Authors:  Lélia Bertoni; Sandrine Jacquet-Guibon; Thomas Branly; Mélanie Desancé; Florence Legendre; Martine Melin; Pascaline Rivory; Daniel-Jean Hartmann; Amandine Schmutz; Jean-Marie Denoix; Magali Demoor; Fabrice Audigié; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2021-03-02       Impact factor: 5.923

9.  Injectable Systems for Intra-Articular Delivery of Mesenchymal Stromal Cells for Cartilage Treatment: A Systematic Review of Preclinical and Clinical Evidence.

Authors:  Alice Roffi; Norimasa Nakamura; Mikel Sanchez; Magali Cucchiarini; Giuseppe Filardo
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

Review 10.  Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee-A Narrative Review.

Authors:  Jennifer Woodell-May; Kathleen Steckbeck; William King
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.